Clinical Trial Update: Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating irinotecan in patients with solid tumors or lymphoma who have abnormal liver or kidney function or prior pelvic radiation; the study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Small Intestine Cancer

Drugs mentioned

• Irinotecan (Irinotecan)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lymphoma, Small Intestine Cancer | Phase 1 | Status: COMPLETED